Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1528 EUR
−3.17 M EUR
10.06 K EUR
57.44 M
About QUANTUM GENOMICS
Sector
CEO
Jean-Philippe Milon
Headquarters
Paris
Website
Founded
2005
ISIN
FR0011648971
FIGI
BBG005P8LG22
Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. It focuses on the development of drug class based on the central action mechanism of Aminopeptidase A inhibition. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALQGC is 0.0721 EUR — it has decreased by −1.77% in the past 24 hours. Watch QUANTUM GENOMICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange QUANTUM GENOMICS stocks are traded under the ticker ALQGC.
ALQGC reached its all-time high on Jun 19, 2015 with the price of 14.2042 EUR, and its all-time low was 0.0010 EUR and was reached on Sep 5, 2024. View more price dynamics on ALQGC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALQGC stock is 4.03% volatile and has beta coefficient of 4.94. Track QUANTUM GENOMICS stock price on the chart and check out the list of the most volatile stocks — is QUANTUM GENOMICS there?
Today QUANTUM GENOMICS has the market capitalization of 5.00 M, it has increased by 1.94% over the last week.
Yes, you can track QUANTUM GENOMICS financials in yearly and quarterly reports right on TradingView.
QUANTUM GENOMICS is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ALQGC net income for the last half-year is −8.22 M EUR, while the previous report showed −1.19 M EUR of net income which accounts for −593.10% change. Track more QUANTUM GENOMICS financial stats to get the full picture.
No, ALQGC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QUANTUM GENOMICS EBITDA is −2.27 M EUR, and current EBITDA margin is −31.26 K%. See more stats in QUANTUM GENOMICS financial statements.
Like other stocks, ALQGC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QUANTUM GENOMICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QUANTUM GENOMICS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QUANTUM GENOMICS stock shows the sell signal. See more of QUANTUM GENOMICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.